注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
NeuroMetrix Inc專注於開發和商業化利用非侵入性神經刺激的保健產品。該公司從事設計、製造和營銷用於診斷和治療目的的刺激神經和分析神經反應的醫療設備。它有兩個主要產品類別,包括即時神經病變診斷測試和可穿戴神經刺激設備。該公司的產品包括DPNCheck、Quell和ADVANCE 系統。DPNCheck是一種定量神經傳導測試,用於評估周圍神經病變,例如糖尿病周圍神經病變 (DPN)。Quell是一種可穿戴設備,用於緩解症狀和管理慢性疼痛。ADVANCE系統是進行神經傳導研究的平台。DPNCheck的客戶包括管理式醫療機構、內分泌學家、足病醫生和初級保健醫生。 ADVANCE系統的客戶涵蓋職業健康、初級保健、內科等。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Shai N. Gozani | 56 | 1996 | Founder, Chairman, CEO, President & Secretary |
Jiro Nakamura | - | 2014 | Member of Scientific Advisory Board |
David E. Goodman | 66 | 2004 | Independent Director |
Bradley M. Fluegel | 61 | 2022 | Independent Director |
Arthur I. Vinik | - | 2011 | Member of Scientific Advisory Board |
Solomon Tesfaye | - | 2011 | Member of the Scientific Advisory Board |
Bruce A. Perkins | - | 2011 | Member of the Scientific Advisory Board |
Neil H. Brooks | - | 2011 | Member of the Scientific Advisory Board |
Nancy E. Katz | 64 | 2010 | Independent Director |
Dan Ziegler | - | 2011 | Member of the Scientific Advisory Board |
Andrew J.M. Boulton | - | 2011 | Member of the Scientific Advisory Board |
David G. Armstrong | - | 2011 | Member of the Scientific Advisory Board |
David Van Avermaete | 72 | 2013 | Independent Director |
Joshua S. Horowitz | 46 | 2024 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核